In Depth 12 Jul 2023 Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden …for the further development of pipeline programs. To create a space for networking, the establishment, which was founded in 1997, has over 300 member companies and hosts around 30 events… July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 25 Nov 2020 How to Weather Bad Press as a Biotech Company …as an emergency team with responsibilities assigned. Many adverse events are things you can prepare a scenario plan for, such as clinical trial failures, product recalls, and unexpected leadership reshuffles…. November 25, 2020 - 7 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2023 Advancing cancer care with 3D genomics …can often be identified that are universally and uniquely shared across certain diseases. This is because they are highly prevalent binary events, with a high signal-to-noise ratio. This approach is… February 1, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2017 Interview: Why Asian CROs are Turning to the European Biotech Market …companies. Can you comment on that in more detail, Steve? “Elbasvir is an NS5A inhibitor, which means that it prevents the replication of the Hepatitis C virus” -Steve Yang American… November 30, 2017 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 8 Nov 2022 Rallybio announces positive phase 1 results for drug treating PNH and gMG …mild or moderate adverse events and no drug-related serious adverse events reported. The ongoing dose escalation study was initiated in February 2022 and is designed to evaluate the safety, pharmacokinetics… November 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Aug 2017 And the Winner for the BioPharm America 2017 FREE Ticket Giveaway is… …Bächle, PhD, Outreach Scientist at Addgene P.S. We are planning on teaming up with a few more events, so we can have more giveaways for our awesome readers (that’s you!)… August 16, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2020 Is Hepatitis D Healthcare Being Overlooked? …hepatitis B infections and causes scarring and liver cancer much more quickly than any other form of hepatitis. The hepatitis B vaccine prevents hepatitis D. However, for those who get… August 20, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Apr 2025 Six biotech companies leading the charge in hemophilia treatment …to the bloodstream. In December 2024, Expression Therapeutics announced promising phase 1 results for its hemophilia gene therapy, demonstrating that no spontaneous bleeding events occurred in any of the five… April 29, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 23 Nov 2022 Tevogen Bio to investigate T cell therapy in long Covid …adverse events. Patients treated were infected with a range of all Covid variants at the time, from Delta through Omicron BA.5. Additionally, each patient had co-morbidities rendering them high risk… November 23, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 30 Mar 2023 Vaccitech announces positive topline data for chronic hepatitis study …completed trial, which included 55 patients with chronic hepatitis B, supported the generally favorable tolerability profile previously reported with VTP-300, with no incidents of VTP-300-related grade 3 adverse events or… March 30, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2022 Authorization given to BeiGene’s chemo-free treatment option for lymphoma …months. It was generally well-tolerated and safety in MZL was consistent with its established profile. BeiGene said the most common grade adverse events (less than 5%) included neutropenia (23%), pneumonia… November 2, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2022 Rani Therapeutics reveals results from phase 1 osteoporosis study …with no serious adverse events (SAEs) noted during the study. None of the participants withdrew from the repeat-dose study due to any adverse event related to the RaniPill capsule or… December 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email